Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. herb pair suppresses breast cancer liver metastasis by targeting ECM1-mediated cholesterol biosynthesis pathway

• Published in: Phytomedicine (Stuttgart) 2023-07, Vol.116, p.154896-154896, Article 154896
• Main Authors: Wang, Jue, Chen, Yueqiang, Luo, Zhanyang, Huang, Qionglian, Zhang, Yu, Ning, Hanjuan, Liu, Sheng, Wang, Jianyi, Han, Xianghui
• Format: Article
• Language: English
• Subjects: breast cancer liver metastasis; Cell Line, Tumor; cholesterol biosynthesis; Citri Reticulatae Pericarpium; extracellular matrix protein 1; Extracellular Matrix Proteins; herb pair; Humans; Liver Neoplasms - drug therapy; Reynoutria; Reynoutria japonica Houtt; Triple Negative Breast Neoplasms - drug therapy
• ISSN: 0944-7113; 1618-095X
• DOI: 10.1016/j.phymed.2023.154896

•Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. herb pair could effectively reduce breast cancer liver metastasis.•ECM1 promotes breast cancer liver metastasis via cholesterol biosynthesis pathway.•The mechanism of Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. herb pair is partially mediated by disrupting the ECM1-activated cholesterol biosynthesis process in TNBC cells. Liver metastasis is a frequent event in breast cancer that causes low survival rate and poor prognosis. Citri Reticulatae Pericarpium-Reynoutria japonica Houtt. (CR), a traditional Chinese herb pair, is used for the treatment of breast cancer liver metastasis or cholesterol gallstone disease in clinics. This study attempted to investigate the potential therapeutic target and mechanism of CR herb pair on breast cancer liver metastasis. The anti-metastatic and cholesterol-lowering activities of CR extract were evaluated in triple-negative breast cancer (TNBC) cell lines and an experimental liver metastasis model. The role of extracellular matrix protein 1 (ECM1) in the cholesterol biosynthesis pathway was determined by the knockdown and overexpression of ECM1 gene of TNBC cells. Changes in the gene and protein expression levels of ECM1 and the cholesterol biosynthesis pathway after CR treatment were detected in vitro and in vivo by real-time PCR and Western blot. The invasive and metastatic potentials and hypercholesterol levels of TNBC cells were positively associated with ECM1 expression. ECM1 knockdown reduced tumor cholesterol levels via downregulating cholesterol biosynthesis genes, including ACAT2, HMGCS1, HMGCR, MVK, and MVD, whereas ECM1 overexpression elicited the opposite effects. CR herb pair exerts the potential therapeutic effects on TNBC liver metastasis, which is partially mediated by disrupting ECM1-activated cholesterol biosynthesis process in TNBC cells. This study reveals that ECM1 is a novel target for the activation of cholesterol biosynthesis to promote TNBC liver metastasis occurrence. CR herb pair, an ECM1 inhibitor, maybe be considered to serve as an adjuvant therapeutic drug for liver metastasis in clinical practice. [Display omitted]